Biopharmaceutical Firm Cerecor Plans To Relocate HQ From Baltimore To Rockville

Cerecor, a publicly traded biopharmaceutical company developing treatments for orphan disorders, is planning to relocate from Baltimore city to Rockville, Md.

According to documents filed with the U.S. Securities and Exchange Commission, the company recently signed a lease for a new 6,000 sq. ft. headquarters in Rockville.

A Cerecor spokesperson said the company plans to move around the end of the year, when its current lease expires at Inner Harbor’s 400 E. Pratt St. Five employees, most of whom already live around Montgomery County, are expected to relocate. The new office will have room for nearly 20 employees. The company currently employs close to 50 people, with many based outside of Maryland.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect